J-113,397

1-[(3R,4R)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-on

1-[(3R,4R)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one

1-[(3R,4R)-1-(Cyclooctylméthyl)-3-(hydroxyméthyl)-4-pipéridinyl]-3-éthyl-1,3-dihydro-2H-benzimidazol-2-one

1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)piperidin-4-yl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one

256640-45-6

2H-Benzimidazol-2-one, 1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-

J-113,397

[Wiki]

(±)-J 113397

1-((3R,4R)-1-Cyclooctylmethyl-3-hydroxymethyl-piperidin-4-yl)-3-ethyl-1,3-dihydro-benzoimidazol-2-one

1-(1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl)-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one

1-[(3R*,4R*)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-Benzimidazol-2-one

1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-2-benzimidazolone

1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidyl]-3-ethyl-benzimidazol-2-one

1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)piperidin-4-yl]-3-ethyl-benzimidazol-2-one

1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)piperidin-4-yl]-3-ethylbenzimidazol-2-one

1-[(3R,4R)-1-(cyclooctylmethyl)-3-methylol-4-piperidyl]-3-ethyl-benzimidazol-2-one

1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one

1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one

1-[(3RS,4RS)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-Benzimidazol-2-one

217461-40-0

MFCD04113003

Nociceptin receptor

OPRD_HUMAN

OPRK_HUMAN

OPRM_HUMAN

OPRX_HUMAN

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor